• BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside.
    • Boussios S, Rassy E, Moschetta M, Ghose A, Adeleke S, Sanchez E, Sheriff M, Chargari C, Pavlidis N.
    • Cancers (Basel). 2022 Aug 11;14(16):3888. doi: 10.3390/cancers14163888.
    • Use of eConsult to enhance genetics service delivery in primary care: A multimethod study.
    • Carroll JC, Liddy C, Afkham A, Keely E, Goh ES, Graham GE, Permaul JA, Allanson J, Heisey R, Makuwaza T, Manca DP, O'Brien MA, Grunfeld E; CanIMPACT.
    • Genet Med. 2022 Aug 9:S1098-3600(22)00840-1. doi: 10.1016/j.gim.2022.07.003. Epub ahead of print.
  • LitAlert ~~ GeneLit.com

    • Long-term survival of a BRCA2 mutation carrier following second ovarian cancer relapse using PARPi therapy: A case report.
    • Bredow K, Blümcke B, Schneider S, Püsken M, Schmutzler R, Rhiem K.
    • Mol Clin Oncol. 2022 Jul 21 [eCollection 2022 Sep];17(3):137. doi: 10.3892/mco.2022.2570.
    • BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside.
    • Boussios S, Rassy E, Moschetta M, Ghose A, Adeleke S, Sanchez E, Sheriff M, Chargari C, Pavlidis N.
    • Cancers (Basel). 2022 Aug 11;14(16):3888. doi: 10.3390/cancers14163888.
    • Complete Response To Talazoparib In Patient With Pancreatic Adenocarcinoma Harbouring Somatic PALB2 Mutation: A Case Report And Literature Review.
    • Kachmazov A, Bolotina L, Kornietskaya A, Kuznetsova O, Ivanov M, Fedenko A.
    • Front Oncol. 2022 Aug 11;12:953908. doi: 10.3389/fonc.2022.953908.
    • Precision Medicine of Hepatobiliary and Pancreatic Cancers: Focusing on Clinical Trial Outcomes.
    • Tsumura T, Doi K, Marusawa H.
    • Cancers (Basel). 2022 Jul 28;14(15):3674. doi: 10.3390/cancers14153674.
    • Do Not Forget Poly (Adenosine Diphosphate-Ribose) Polymerase Inhibitors in Ovarian Carcinosarcoma.
    • Magalhães D, Bartosch C, Abreu MH.
    • Cureus. 2022 Jul 8;14(7):e26662. doi: 10.7759/cureus.26662.
  • LitAlert ~~ GeneLit.com

    • Long-term survival of a BRCA2 mutation carrier following second ovarian cancer relapse using PARPi therapy: A case report.
    • Bredow K, Blümcke B, Schneider S, Püsken M, Schmutzler R, Rhiem K.
    • Mol Clin Oncol. 2022 Jul 21 [eCollection 2022 Sep];17(3):137. doi: 10.3892/mco.2022.2570.
    • HBOC syndrome with an uncharacterized variant in the BRCA1 gene in a patient diagnosed with endometrial cancer after surgery for bilateral breast cancer: A case report.
    • Mabuchi Y, Hamano Y, Minami S, Ota N, Ino K.
    • Oncol Lett. 2022 Jul 27 [eCollection 2022 Sep];24(3):325. doi: 10.3892/ol.2022.13445.
    • BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside.
    • Boussios S, Rassy E, Moschetta M, Ghose A, Adeleke S, Sanchez E, Sheriff M, Chargari C, Pavlidis N.
    • Cancers (Basel). 2022 Aug 11;14(16):3888. doi: 10.3390/cancers14163888.
    • Complete Response To Talazoparib In Patient With Pancreatic Adenocarcinoma Harbouring Somatic PALB2 Mutation: A Case Report And Literature Review.
    • Kachmazov A, Bolotina L, Kornietskaya A, Kuznetsova O, Ivanov M, Fedenko A.
    • Front Oncol. 2022 Aug 11;12:953908. doi: 10.3389/fonc.2022.953908.
    • Precision Medicine of Hepatobiliary and Pancreatic Cancers: Focusing on Clinical Trial Outcomes.
    • Tsumura T, Doi K, Marusawa H.
    • Cancers (Basel). 2022 Jul 28;14(15):3674. doi: 10.3390/cancers14153674.
    • Do Not Forget Poly (Adenosine Diphosphate-Ribose) Polymerase Inhibitors in Ovarian Carcinosarcoma.
    • Magalhães D, Bartosch C, Abreu MH.
    • Cureus. 2022 Jul 8;14(7):e26662. doi: 10.7759/cureus.26662.
    • Screening of BRCA1 (c.5177_5180delGAAA rs80357867 and c.4986+6T>C rs80358086) and the BRCA2 (c.6445_6446delAT rs80359592) Genes for Breast Cancer Prevention in Burkina Faso.
    • Kiendrebeogo IT, Zoure AA, Zongo FI, Ouedraogo SY, Sawadogo AY, Amegnona J, Sombie HK, Bazie JTVE, Sorgho PA, Yonli AT, Ouedraogo MNL, Obiri-Yeboah D, Zongo N, Bambara HA, Simpore J.
    • Ethiop J Health Sci. 2022 Jul;32(4):699-708. doi: 10.4314/ejhs.v32i4.5.
  • LitAlert ~~ GeneLit.com

    • HBOC syndrome with an uncharacterized variant in the BRCA1 gene in a patient diagnosed with endometrial cancer after surgery for bilateral breast cancer: A case report.
    • Mabuchi Y, Hamano Y, Minami S, Ota N, Ino K.
    • Oncol Lett. 2022 Jul 27 [eCollection 2022 Sep];24(3):325. doi: 10.3892/ol.2022.13445.
    • BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside.
    • Boussios S, Rassy E, Moschetta M, Ghose A, Adeleke S, Sanchez E, Sheriff M, Chargari C, Pavlidis N.
    • Cancers (Basel). 2022 Aug 11;14(16):3888. doi: 10.3390/cancers14163888.
    • Do Not Forget Poly (Adenosine Diphosphate-Ribose) Polymerase Inhibitors in Ovarian Carcinosarcoma.
    • Magalhães D, Bartosch C, Abreu MH.
    • Cureus. 2022 Jul 8;14(7):e26662. doi: 10.7759/cureus.26662.
    • Screening of BRCA1 (c.5177_5180delGAAA rs80357867 and c.4986+6T>C rs80358086) and the BRCA2 (c.6445_6446delAT rs80359592) Genes for Breast Cancer Prevention in Burkina Faso.
    • Kiendrebeogo IT, Zoure AA, Zongo FI, Ouedraogo SY, Sawadogo AY, Amegnona J, Sombie HK, Bazie JTVE, Sorgho PA, Yonli AT, Ouedraogo MNL, Obiri-Yeboah D, Zongo N, Bambara HA, Simpore J.
    • Ethiop J Health Sci. 2022 Jul;32(4):699-708. doi: 10.4314/ejhs.v32i4.5.
  • LitAlert ~~ GeneLit.com

    • Environmental scan of family chart linking for genetic cascade screening in a U.S. integrated health system.
    • Haas CB, Ralston J, Fullerton SM, Scrol A, Henrikson NB.
    • Front Genet. 2022 Aug 11;12:886650. doi: 10.3389/fgene.2022.886650.
    • Use of eConsult to enhance genetics service delivery in primary care: A multimethod study.
    • Carroll JC, Liddy C, Afkham A, Keely E, Goh ES, Graham GE, Permaul JA, Allanson J, Heisey R, Makuwaza T, Manca DP, O'Brien MA, Grunfeld E; CanIMPACT.
    • Genet Med. 2022 Aug 9:S1098-3600(22)00840-1. doi: 10.1016/j.gim.2022.07.003. Epub ahead of print.
  • LitAlert ~~ GeneLit.com

    • HBOC syndrome with an uncharacterized variant in the BRCA1 gene in a patient diagnosed with endometrial cancer after surgery for bilateral breast cancer: A case report.
    • Mabuchi Y, Hamano Y, Minami S, Ota N, Ino K.
    • Oncol Lett. 2022 Jul 27 [eCollection 2022 Sep];24(3):325. doi: 10.3892/ol.2022.13445.
    • Environmental scan of family chart linking for genetic cascade screening in a U.S. integrated health system.
    • Haas CB, Ralston J, Fullerton SM, Scrol A, Henrikson NB.
    • Front Genet. 2022 Aug 11;12:886650. doi: 10.3389/fgene.2022.886650.
  • LitAlert ~~ GeneLit.com

    • Dual BRCA1 and BRCA2 pathogenic variants in an adolescent with syndromic intellectual disability.
    • Algouneh A, Caudle M, Balci T, Andrade A, Penava D, Saleh M.
    • Clin Case Rep. 2022 Aug 8;10(8):e6202. doi: 10.1002/ccr3.6202.
    • RAD54B mutations enhance the sensitivity of ovarian cancer cells to poly(ADP-ribose) polymerase (PARP) inhibitors.
    • Liu P, Lin C, Liu L, Lu Z, Tu Z, Liu H.
    • J Biol Chem. 2022 Aug 8:102354. doi: 10.1016/j.jbc.2022.102354. Epub ahead of print.
    • Precision Medicine of Hepatobiliary and Pancreatic Cancers: Focusing on Clinical Trial Outcomes.
    • Tsumura T, Doi K, Marusawa H.
    • Cancers (Basel). 2022 Jul 28;14(15):3674. doi: 10.3390/cancers14153674.
    • Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation.
    • Blasi PR, Scrol A, Anderson ML, Gray MF, Tiffany B, Fullerton SM, Ralston JD, Leppig KA, Henrikson NB.
    • Pilot Feasibility Stud. 2022 Aug 9;8(1):174. doi: 10.1186/s40814-022-01142-9.